267 related articles for article (PubMed ID: 20646322)
1. Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.
Yin S; Sun S; Yang S; Shang Y; Cai X; Liu X
Virol J; 2010 Jul; 7():166. PubMed ID: 20646322
[TBL] [Abstract][Full Text] [Related]
2. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
3. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
4. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
[TBL] [Abstract][Full Text] [Related]
5. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
6. Purification of recombinant virus-like particles of porcine circovirus type 2 capsid protein using ion-exchange monolith chromatography.
Zaveckas M; Snipaitis S; Pesliakas H; Nainys J; Gedvilaite A
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():21-8. PubMed ID: 25910233
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
9. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
[TBL] [Abstract][Full Text] [Related]
10. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
[TBL] [Abstract][Full Text] [Related]
11. The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development.
Chi JN; Wu CY; Chien MS; Wu PC; Wu CM; Huang C
J Biotechnol; 2014 Jul; 181():12-9. PubMed ID: 24739460
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies.
Marcekova Z; Psikal I; Kosinova E; Benada O; Sebo P; Bumba L
J Virol Methods; 2009 Dec; 162(1-2):133-41. PubMed ID: 19664658
[TBL] [Abstract][Full Text] [Related]
13. Preparation of virus-like particles for porcine circovirus type 2 by YeastFab Assembly.
Chen P; Zhang L; Chang N; Shi P; Gao T; Zhang L; Huang J
Virus Genes; 2018 Apr; 54(2):246-255. PubMed ID: 29417333
[TBL] [Abstract][Full Text] [Related]
14. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
15. Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative.
Aguilera BE; Chávez-Calvillo G; Elizondo-Quiroga D; Jimenez-García MN; Carrillo-Tripp M; Silva-Rosales L; Hernández-Gutiérrez R; Gutiérrez-Ortega A
Biotechnol Appl Biochem; 2017 May; 64(3):406-414. PubMed ID: 26970530
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
Wang Y; Xu F; Yuan C; Zhang Y; Ren J; Yue H; Ma T; Song Q
Vaccine; 2024 Apr; 42(11):2848-2857. PubMed ID: 38514351
[TBL] [Abstract][Full Text] [Related]
17. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
Liu X; Liu Y; Zhang Y; Zhang F; Du E
BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
[TBL] [Abstract][Full Text] [Related]
20. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
